Synthesis of 1,4-dihydro-2-phenyl-4,4-bis(4-pyridinylmethyl)-2H-isoquinolin-3-one and related compounds as acetylcholine release enhancers

Mei Shan Lin, Ling Wei Hsin, Hui Bing Tsai, Ming Cheng Tsai, Chen Yu Cheng

研究成果: 雜誌貢獻文章同行評審

1 引文 斯高帕斯(Scopus)

摘要

Acetylcholine release enhancers may have therapeutic value in the treatment of Alzheimer's disease. A series of 1,4-dihydro-4,4-bis(pyridinylmethyl)-2H-isoquinolin-3-ones (2-13) was synthesized as analogs of the known acetylcholine-release enhancer linopirdine (1). Their cholinergic activity was measured as the enhancement of indirectly-elicited twitch tension of the mouse diaphragm. Among the target compounds, 2-phenyl-4,4-bis(4-pyridinylmethyl)-4H-isoquinoline-1,3-dione (2) and 7-bromo-1,4-dihydro-2-phenyl-4,4-bis(4-pyridinylmethyl)-2H-isoquinolin-3-one (11) were found to be more potent than 1.
原文英語
頁(從 - 到)271-281
頁數11
期刊Chinese Pharmaceutical Journal
54
發行號4
出版狀態已發佈 - 八月 2002

Keywords

  • Acetylcholine release enhancers
  • Alzheimer's disease
  • Linopirdine

ASJC Scopus subject areas

  • 藥理
  • 藥學科學

指紋

深入研究「Synthesis of 1,4-dihydro-2-phenyl-4,4-bis(4-pyridinylmethyl)-2H-isoquinolin-3-one and related compounds as acetylcholine release enhancers」主題。共同形成了獨特的指紋。

引用此